At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
Exalt Model D Single-Use Duodenoscopedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience
In Brief
A clinical study evaluating Exalt Model D Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography. Completed, enrolled 200 participants across 7 sites in 2 countries.
Detailed Summary
The objective of this study is to confirm procedural performance of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands, United States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartJan 2020
Primary CompletionFeb 2021
Study CompletionMar 2021
TodayJul 2026
First PostedJan 10, 2020
Enrollment StartJan 14, 2020
Primary CompletionFeb 22, 2021
Study CompletionMar 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.5 years ago
Interventions
Exalt Model D Single-Use Duodenoscopedevice
Subjects will have a clinically indicated per standard of care endoscopic retrograde cholangiopancreatography (ERCP) or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device.